TRANSLATE BIO, INC.
🏢 View company profile →132Patents
132Active
132Granted
59Portfolio score
Filing activity: Mar 13, 2013 → Aug 7, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9850269B2 | Methods for purification of messenger RNA | Chemistry; Metallurgy | 36 | Active |
| US10238754B2 | Lipid nanoparticle compositions and methods for MRNA delivery | Human Necessities | 27 | Active |
| US9957499B2 | Methods for purification of messenger RNA | Chemistry; Metallurgy | 25 | Active |
| US10413618B2 | Lipid nanoparticle compositions and methods for mRNA delivery | Human Necessities | 22 | Active |
| US10350303B1 | Lipid nanoparticle compositions and methods for mRNA delivery | Human Necessities | 22 | Active |
| US9877919B2 | Lipid-derived neutral nanoparticles | Chemistry; Metallurgy | 19 | Active |
| US10143758B2 | Liver specific delivery of messenger RNA | Chemistry; Metallurgy | 19 | Active |
| US10208295B2 | MRNA therapy for phenylketonuria | Human Necessities | 18 | Active |
| US10507249B2 | Lipid nanoparticle compositions and methods for mRNA delivery | Human Necessities | 14 | Active |
| US10155785B2 | Methods for purification of messenger RNA | Chemistry; Metallurgy | 13 | Active |
| US10052284B2 | Lipid formulations for delivery of messenger RNA | Human Necessities | 13 | Active |
| US10888626B2 | Lipid nanoparticle compositions and methods for mRNA delivery | Human Necessities | 12 | Active |
| US10022455B2 | Biodegradable lipids for delivery of nucleic acids | Chemistry; Metallurgy | 12 | Active |
| US9970047B2 | Quantitative assessment for cap efficiency of messenger RNA | Chemistry; Metallurgy | 12 | Active |
| US11052159B2 | Lipid nanoparticle compositions and methods for mRNA delivery | Human Necessities | 10 | Active |
| US11291734B2 | Lipid nanoparticle compositions and methods for mRNA delivery | Human Necessities | 9 | Active |
| US10130649B2 | Synergistic enhancement of the delivery of nucleic acids via blended formulations | Physics | 9 | Active |
| US9943595B2 | Messenger RNA therapy for treatment of articular disease | Human Necessities | 8 | Active |
| US10471153B2 | Ice-based lipid nanoparticle formulation for delivery of mRNA | Human Necessities | 8 | Active |
| US11059841B2 | Methods for purification of messenger RNA | Chemistry; Metallurgy | 8 | Active |
| US10087247B2 | Methods and compositions for delivering mRNA coded antibodies | Chemistry; Metallurgy | 8 | Active |
| US10144942B2 | Modification of RNA-related enzymes for enhanced production | Chemistry; Metallurgy | 7 | Active |
| US11185595B2 | Lipid nanoparticle compositions and methods for mRNA delivery | Human Necessities | 7 | Active |
| US10137087B2 | Lipid-derived neutral nanoparticles | Chemistry; Metallurgy | 6 | Active |
| US10702478B2 | Cleavable lipids | Chemistry; Metallurgy | 6 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.